1224802

丁二酸二辛酯磺酸钠

United States Pharmacopeia (USP) Reference Standard

• 同義詞: 多库酯 钠盐, AOT, 二辛基琥珀酸磺酸钠 钠盐, 双(2-乙基己基)磺基琥珀酸钠, 双(2-乙己基)磺基丁二酸钠 钠盐, 磺基丁二酸钠二辛酯 钠盐, 磺基琥珀酸二乙基己酯钠 钠盐
• 經驗公式（希爾表示法）: C₂₀H₃₇NaO₇S
• CAS號碼: 577-11-7
• 分子量：: 444.56
• Beilstein: 4117588
• MDL號碼: MFCD00012455
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329749663
• NACRES: NA.24

屬性

• 等級: pharmaceutical primary standard
• API 家族: docusate calcium
• 製造商／商標名: USP
• 應用: pharmaceutical (small molecule)
• 格式: neat
• SMILES 字串: [Na+].CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S([O-])(=O)=O
• InChI: 1S/C20H38O7S.Na/c1-5-9-11-16(7-3)14-26-19(21)13-18(28(23,24)25)20(22)27-15-17(8-4)12-10-6-2;/h16-18H,5-15H2,1-4H3,(H,23,24,25);/q;+1/p-1
• InChI 密鑰: APSBXTVYXVQYAB-UHFFFAOYSA-M

描述

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Docusate sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Docusate Sodium Solution
• Docusate Sodium Tablets
• Docusate Sodium Syrup
• Docusate Sodium Capsules
• Ferrous Fumarate and Docusate Sodium Extended-Release Tablets
• Docusate Potassium Capsules

在烃类溶剂中形成反相胶束；适合于溶解主要的髓鞘跨膜蛋白脂质

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS05
• 訊號詞: Danger
• 危險聲明: H315,H318
• 防範說明: P264 - P280 - P302 + P352 - P305 + P351 + P338 - P332 + P313 - P362 + P364
• 危險分類: Eye Dam. 1 - Skin Irrit. 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 2